A phase II study of the combination of liposomal doxorubicin (LD) and gemcitabine (G) in patients with relapsed ovarian cancer after chemotherapy containing platinum compounds.

被引：0
|
作者：
Gambino, A [1 ]
Tognon, G [1 ]
Galleri, G [1 ]
Agoni, L [1 ]
Pecorelli, S [1 ]
机构：
[1] Univ Studi, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492S / 492S
页数：1
相关论文
共 50 条
  • [31] Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine
    Ledermann, J. A.
    Gabra, H.
    Jayson, G. C.
    Spanswick, V. J.
    Rustin, G. J.
    Jitlal, M.
    James, L. E.
    Hartley, J. A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 320 - 320
  • [32] A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy
    Sehouli, J
    Stengel, D
    Oskay, G
    Camara, O
    Hindenburg, HJ
    Klare, P
    Blohmer, J
    Heinrich, G
    Elling, D
    Ledwon, P
    Lichtenegger, W
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1749 - 1755
  • [33] Weekly gemcitabine in patients with relapsed platinum-resistant ovarian or peritoneal cancer. Results of phase II study
    Czerniawska, Malgorzata
    Jagiello-Gruszfeld, Agnieszka
    Zbrzezniak, Jolanta
    Wachula, Ewa
    Szablowska-Siwik, Sylwia
    Sikorska, Magdalena
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [34] Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer
    Gordon, AN
    Granai, CO
    Rose, PG
    Hainsworth, J
    Lopez, A
    Weissman, C
    Rosales, R
    Sharpington, T
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3093 - 3100
  • [35] Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Syrewicz, L
    Rahman, Z
    Esteva, FL
    Theriault, RL
    Rosales, MM
    Booser, D
    Murray, JL
    Bast, RC
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1716 - 1722
  • [36] Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer:: results of a multicenter phase-II trial
    Sehouli, J
    Oskay-Özcelik, G
    Kühne, J
    Stengel, D
    Hindenburg, HJ
    Klare, P
    Heinrich, G
    Schmalfeldt, B
    Mertens, H
    Camara, O
    Lichtenegger, W
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 957 - 961
  • [37] Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
    Vergote, Ignace
    Finkler, Neil J.
    Hall, James B.
    Melnyk, Ostap
    Edwards, Robert P.
    Jones, Marsha
    Keck, James G.
    Meng, Lisa
    Brown, Gail L.
    Rankin, Elaine M.
    Burke, James J.
    Boccia, Ralph V.
    Runowicz, Carolyn D.
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 772 - 780
  • [38] Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients
    Bourgeois, Hugues
    Joly, Florence
    Pujade-Lauraine, Eric
    Cure, Herve
    Guastalla, Jean Paul
    Ferru, Aurelie
    Chabrun, Virginie
    Chieze, Stephanie
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 399 - 404
  • [39] Phase II Austrian AGO study of pegylated liposomal doxorubicin and gemcitabine in platinum-refractory and resistant ovarian cancer following previous platinum-taxane therapy
    Petru, E.
    Angleitner-Boubenizek, L.
    Reinthaller, A.
    Zeimet, A. G.
    Stempfl, A.
    Volgger, B.
    Deibl, M.
    Denison, U.
    Bogner, G.
    Marth, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 266 - 267
  • [40] Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
    Rapoport, B. L.
    Vorobiof, D. A.
    Slabber, C.
    Alberts, A. S.
    Hlophe, H. S.
    Mohammed, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1137 - 1141
12345